123 related articles for article (PubMed ID: 38006863)
21. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
22. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract][Full Text] [Related]
23. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
Chen JF; Yang C; Sun Y; Cao D
Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
[TBL] [Abstract][Full Text] [Related]
24. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
Ali AS; Grönberg M; Federspiel B; Scoazec JY; Hjortland GO; Grønbæk H; Ladekarl M; Langer SW; Welin S; Vestermark LW; Arola J; Österlund P; Knigge U; Sorbye H; Grimelius L; Janson ET
PLoS One; 2017; 12(11):e0187667. PubMed ID: 29112960
[TBL] [Abstract][Full Text] [Related]
25. A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasms.
Liu B; Kudo A; Kinowaki Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tanaka S; Akashi T; Tanabe M
J Gastroenterol; 2019 Sep; 54(9):819-828. PubMed ID: 30863885
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis.
Ogawa H; Tanaka Y; Kitamura Y; Shimizu N; Doi T; Hokka D; Tane S; Nishio W; Yoshimura M; Maniwa Y
J Thorac Dis; 2019 Apr; 11(4):1145-1154. PubMed ID: 31179056
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Nakanishi T; Hasumi Y; Iwata T; Baba T; Nogawa T; Kudaka W; Kaneda H; Ono S; Saito F; Taniguchi Y; Okada S; Mizuno M; Onda T; Yaegashi N
Gynecol Oncol; 2018 Jan; 148(1):139-146. PubMed ID: 29113721
[TBL] [Abstract][Full Text] [Related]
29. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features and prognostic factors analysis of multiple synchronous distinct subtypes of primary thyroid carcinoma.
Dai Q; Fu X; Ding Y; He Q; Qiu X
Endocrine; 2023 Mar; 79(3):491-501. PubMed ID: 36399310
[TBL] [Abstract][Full Text] [Related]
31. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
32. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
33. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
34. Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis.
Huang R; Yu L; Zheng C; Liang Q; Suye S; Yang X; Yin H; Ren Z; Shi L; Zhang Z; Chen H; Fu C
Sci Rep; 2020 Sep; 10(1):14975. PubMed ID: 32917946
[TBL] [Abstract][Full Text] [Related]
35. [The prognostic relationship between CD56 expression and newly diagnosed multiple myeloma].
Geng CY; Yang GZ; Wang HJ; Zhou HX; Zhang ZY; Jian Y; Chen WM
Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):164-171. PubMed ID: 35090251
[No Abstract] [Full Text] [Related]
36. Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation.
Geng C; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Yang G; Chen W
BMC Cancer; 2022 Dec; 22(1):1349. PubMed ID: 36564753
[TBL] [Abstract][Full Text] [Related]
37. CD56 expression in basaloid anal squamous cell carcinoma - A potential diagnostic pitfall.
Madahian S; Judelson R; Zhu X; Meng X; Dresser K; Hutchinson L; Bledsoe JR
Ann Diagn Pathol; 2021 Aug; 53():151758. PubMed ID: 33989959
[TBL] [Abstract][Full Text] [Related]
38. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
Zou Q; Zhang L; Cheng Z; Guo X; Cao D
Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
[TBL] [Abstract][Full Text] [Related]
39. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.
Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L
Front Immunol; 2022; 13():829366. PubMed ID: 35371002
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
